Concepedia

Bingbing Lu

BL

Statistics

Publications

9

Citations

337

H-Index

9

Active since

2018

Affiliations

Henan Cancer Hospital(Current)

Zhengzhou University

China-US (Henan) Hormel Cancer Institute

Chinese Center For Disease Control and Prevention

University of Minnesota

Bingbing Lu is an author at Henan Cancer Hospital specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2018–2024

9

Publications

9

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2

Penglei Wang, Xuechao Jia, Bingbing Lu et al. · Signal Transduction and Targeted Therapy · 2023 · 93 citations · Full text

, , +17

CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction

Yiu To Yeung, Suyu Fan, Bingbing Lu et al. · Carcinogenesis · 2019 · 65 citations · Full text

, , +17

Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer

Xuejiao Liu, Simin Zhao, Keke Wang et al. · Nature Communications · 2023 · 51 citations · Full text

, , +15

Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization

Yiu To Yeung, Shuying Yin, Bingbing Lu et al. · EBioMedicine · 2018 · 39 citations · Full text

, , +16

Mefloquine Inhibits Esophageal Squamous Cell Carcinoma Tumor Growth by Inducing Mitochondrial Autophagy

Yifei Xie, Jing Zhang, Bingbing Lu et al. · Frontiers in Oncology · 2020 · 25 citations · Full text

, , +17

1–5 of 9